Market Forecast by Countries (South Africa, Nigeria, Kenya, Rest of Africa), By Study Design (Interventional, Expanded Access, Observational), By Indication (Cardiovascular, Oncology, Others) And Competitive Landscape
Product Code: ETC077178 | Publication Date: Aug 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
In Africa, the prominent factors favouring the market growth include scarcity of time in traditional clinical trials, rising R&D for the development of new drugs and vaccines, adoption of telemedicine and increasing demand for patient diversity. Though in this region a marked social and economic inequality can still be noticed, over the last years there has been a growth in middle classes and a stronger focus on educational and health sectors. Biopharma companies and regulatory agencies are focused on the creation of digital technologies, virtual trials, and telemedicine, as they're potential solutions to limit trial disruptions. Data security is another potential challenge. Large amounts of patients’ personal data are transmitted via the Internet. They need to ensure patients are aware of the risk of data breaches in the informed consent form. COVID-19 is making virtual and decentralized approaches to clinical trials necessary. Additionally, COVID-19 pandemic has led to upsurge virtual clinical trials given the trials need to be conducted digitally.
According the 6Wresearch, the Africa Virtual Clinical Trials Market is likely to witness significant growth during 2021-2027. Regional cooperation plays an important role not only in sharing knowledge and best practices, but also in strengthening research and coordinating and developing critical treatment strategies, including effective interventions, vaccines, and other drugs. The insufficient number of clinical trials in Africa will continue to magnify the global disparities of cancer in the African population. The different platform in Africa intends to use the funds to launch telemedicine, enabling medical practitioners to offer virtual consultations.
The Africa Virtual Clinical trial market is segmented on the basis of Study type, By indication, and by Regions. Based on study type the market is bifurcated into Interventional, observational and expanded access and others. Based on Indication the market bifurcated into Oncology, cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and other indications. Based on region the market is divided into North America, Latin America, Middle east, Africa, Europe and Asia Pacific. The existence of the leading players and benefits environment for carrying out clinical trials is another element anticipated to push the growth of the clinical trial in the regions. The Key players profiled Virtual clinical trial market are Chiltern, Omnicare, PPD, kendle, Quintles, ICON PLC, Charles River, Parexel. An increasing number of biotechnology firms are looking at the Latin America region for the Covid19 trials to take advantage of the large patient pool and fast track procedures. An increasing number of biotechnology firms are looking at the Europe region for the Covid19 trials to take advantage of the large patient pool and fast track procedures.
The Africa Virtual Clinical trial market report thoroughly covers the market by study, indications and key countries including Nigeria, Egypt, Morocco, Uganda, Zimbabwe. The Africa Virtual Clinical Trial market outlook report provides an unbiased and detailed analysis of the on-going Africa market trends, high growth areas and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Markets Covered
The Market Report covers the following segment:
Other Key Reports Available:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Virtual Clinical Trials Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Virtual Clinical Trials Market Revenues & Volume, 2020 & 2027F |
3.3 Africa Virtual Clinical Trials Market - Industry Life Cycle |
3.4 Africa Virtual Clinical Trials Market - Porter's Five Forces |
3.5 Africa Virtual Clinical Trials Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Africa Virtual Clinical Trials Market Revenues & Volume Share, By Study Design, 2020 & 2027F |
3.7 Africa Virtual Clinical Trials Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Africa Virtual Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Virtual Clinical Trials Market Trends |
6 Africa Virtual Clinical Trials Market, 2017 - 2027 |
6.1 Africa Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
6.2 Africa Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
7 South Africa Virtual Clinical Trials Market, 2017 - 2027 |
7.1 South Africa Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
7.2 South Africa Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
8 Nigeria Virtual Clinical Trials Market, 2017 - 2027 |
8.1 Nigeria Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
8.2 Nigeria Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
9 Kenya Virtual Clinical Trials Market, 2017 - 2027 |
9.1 Kenya Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
9.2 Kenya Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
10 Rest of Africa Virtual Clinical Trials Market, 2017 - 2027 |
10.1 Rest of Africa Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
10.2 Rest of Africa Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
11 Africa Virtual Clinical Trials Market Key Performance Indicators |
12 Africa Virtual Clinical Trials Market - Opportunity Assessment |
12.1 Africa Virtual Clinical Trials Market Opportunity Assessment, By Countries, 2020 & 2027F |
12.2 Africa Virtual Clinical Trials Market Opportunity Assessment, By Study Design, 2020 & 2027F |
12.3 Africa Virtual Clinical Trials Market Opportunity Assessment, By Indication, 2020 & 2027F |
13 Africa Virtual Clinical Trials Market - Competitive Landscape |
13.1 Africa Virtual Clinical Trials Market Revenue Share, By Companies, 2020 |
13.2 Africa Virtual Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
14 Company Profiles |
15 Recommendations |
16 Disclaimer |